Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × Hydroxyurea × Clear all

NCT01521299 2012-08-28

A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Advanced Solid Tumors